299 related articles for article (PubMed ID: 17184289)
1. Significance of human beta-defensins in the epithelial lining fluid of patients with chronic lower respiratory tract infections.
Yanagi S; Ashitani J; Imai K; Kyoraku Y; Sano A; Matsumoto N; Nakazato M
Clin Microbiol Infect; 2007 Jan; 13(1):63-9. PubMed ID: 17184289
[TBL] [Abstract][Full Text] [Related]
2. Isolation of human beta-defensin-4 in lung tissue and its increase in lower respiratory tract infection.
Yanagi S; Ashitani J; Ishimoto H; Date Y; Mukae H; Chino N; Nakazato M
Respir Res; 2005 Nov; 6(1):130. PubMed ID: 16269090
[TBL] [Abstract][Full Text] [Related]
3. Elevated BALF concentrations of alpha- and beta-defensins in patients with pulmonary alveolar proteinosis.
Mukae H; Ishimoto H; Yanagi S; Ishii H; Nakayama S; Ashitani J; Nakazato M; Kohno S
Respir Med; 2007 Apr; 101(4):715-21. PubMed ID: 17000097
[TBL] [Abstract][Full Text] [Related]
4. [Serum level of Pseudomonas aeruginosa-specific IgA in patients with chronic lower respiratory tract infection and its clinical significance].
Tsukada H; Suzuki E; Wada K; Arakawa M
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Oct; 31(10):1227-34. PubMed ID: 8271654
[TBL] [Abstract][Full Text] [Related]
5. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study.
Pressler T; Frederiksen B; Skov M; Garred P; Koch C; Høiby N
J Cyst Fibros; 2006 Jan; 5(1):9-15. PubMed ID: 16412706
[TBL] [Abstract][Full Text] [Related]
6. Expression of human beta-defensins in patients with mycosis fungoides.
Gambichler T; Skrygan M; Appelhans C; Tomi NS; Reinacher-Schick A; Altmeyer P; Kreuter A
Arch Dermatol Res; 2007 Jul; 299(4):221-4. PubMed ID: 17415576
[TBL] [Abstract][Full Text] [Related]
7. Suppression of pulmonary innate host defence in smokers.
Herr C; Beisswenger C; Hess C; Kandler K; Suttorp N; Welte T; Schroeder JM; Vogelmeier C;
Thorax; 2009 Feb; 64(2):144-9. PubMed ID: 18852155
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the biological characteristics of mucoid and non-mucoid Pseudomonas aeruginosa strains isolated from chronic respiratory infections.
Meitert E; Sima F; Savulian C; Chersulick E; Sălăgeanu A
Arch Roum Pathol Exp Microbiol; 1989; 48(3):193-207. PubMed ID: 2519631
[TBL] [Abstract][Full Text] [Related]
9. Pattern of mRNA expression of beta-defensins in basal cell carcinoma.
Gambichler T; Skrygan M; Huyn J; Bechara FG; Sand M; Altmeyer P; Kreuter A
BMC Cancer; 2006 Jun; 6():163. PubMed ID: 16796735
[TBL] [Abstract][Full Text] [Related]
10. Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.
Hiratsuka T; Mukae H; Iiboshi H; Ashitani J; Nabeshima K; Minematsu T; Chino N; Ihi T; Kohno S; Nakazato M
Thorax; 2003 May; 58(5):425-30. PubMed ID: 12728165
[TBL] [Abstract][Full Text] [Related]
11. Suppression of interleukin (IL)-8 and human beta defensin-2 secretion in LPS-and/or IL-1β-stimulated airway epithelial A549 cells by a herbal formulation against respiratory infections (BNO 1030).
Hostanska K; Melzer J; Amon A; Saller R
J Ethnopharmacol; 2011 Mar; 134(2):228-33. PubMed ID: 21167927
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of antimicrobial peptides in bronchoalveolar lavage fluid in patients with chronic eosinophilic pneumonia.
Ashitani J; Matsumoto N; Nakazato M
Respiration; 2007; 74(1):69-75. PubMed ID: 16369124
[TBL] [Abstract][Full Text] [Related]
13. Expression of human beta-defensins-1 and -2 peptides in unresolved chronic periodontitis.
Lu Q; Jin L; Darveau RP; Samaranayake LP
J Periodontal Res; 2004 Aug; 39(4):221-7. PubMed ID: 15206914
[TBL] [Abstract][Full Text] [Related]
14. Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003).
Shigemura K; Arakawa S; Sakai Y; Kinoshita S; Tanaka K; Fujisawa M
Int J Urol; 2006 May; 13(5):538-42. PubMed ID: 16771722
[TBL] [Abstract][Full Text] [Related]
15. [The human beta-defensins expression in female genital tract and pregnancy-related tissues].
Feng Y; Pan X; Huang N; Feng Y; Wu Q; Wang B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):217-9. PubMed ID: 12947693
[TBL] [Abstract][Full Text] [Related]
16. In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model.
Morinaga Y; Yanagihara K; Nakamura S; Yamamoto K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Kamihira S
J Antimicrob Chemother; 2008 Dec; 62(6):1326-31. PubMed ID: 18835805
[TBL] [Abstract][Full Text] [Related]
17. Expression of beta-defensins in gingival health and in periodontal disease.
Bissell J; Joly S; Johnson GK; Organ CC; Dawson D; McCray PB; Guthmiller JM
J Oral Pathol Med; 2004 May; 33(5):278-85. PubMed ID: 15078488
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum beta-defensins concentrations in patients with lung cancer.
Arimura Y; Ashitani J; Yanagi S; Tokojima M; Abe K; Mukae H; Nakazato M
Anticancer Res; 2004; 24(6):4051-7. PubMed ID: 15736451
[TBL] [Abstract][Full Text] [Related]
19. The role of recombinant human elafin in the resistance of A549 cells against Pseudomonas aeruginosa biofilm.
Li Q; Zhou X; Nie X; Yang J
Respiration; 2010; 79(1):68-75. PubMed ID: 19420899
[TBL] [Abstract][Full Text] [Related]
20. [The relationship between different serological types of Pseudomonas aeruginosa strain in lower respiratory tract and its clinical significance].
He G; Li H; Xu H
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):584-7. PubMed ID: 11477871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
